Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| SARC | rs16854051 | chr4:42123892 | A/G | 1.88E-5 | 258 | 18.4 | 32.78 | 33.95 | KM Plot |
| SARC | rs16902863 | chr8:129415706 | T/G | 1.99E-13 | 257 | 33.95 | 23.17 | 3.97 | KM Plot |
| SARC | rs16902889 | chr8:129424715 | G/C | 1.74E-13 | 258 | 33.9 | 23.17 | 3.97 | KM Plot |
| SARC | rs16902895 | chr8:129425593 | A/G | 1.74E-13 | 258 | 33.9 | 23.17 | 3.97 | KM Plot |
| SARC | rs16929655 | chr12:26083873 | G/A | 2.89E-6 | 256 | 33.9 | 27.25 | 16.17 | KM Plot |
| SARC | rs16929667 | chr12:26088424 | C/G | 9.42E-8 | 258 | 33.55 | 29.9 | 13.57 | KM Plot |
| SARC | rs16939689 | chr16:85813740 | A/C | 0 | 258 | 32.5 | 27.1 | 1.07 | KM Plot |
| SARC | rs16962098 | chr13:104004001 | A/G | 0 | 258 | 1.07 | 35.77 | 31.02 | KM Plot |
| SARC | rs16970052 | chr15:40251932 | C/T | 3.2E-6 | 258 | 17.1 | 32.6 | 32.78 | KM Plot |
| SARC | rs17008537 | chr4:164639989 | G/T | 2.42E-14 | 258 | 1.17 | 27.1 | 32.5 | KM Plot |
| SARC | rs17052727 | chr3:53070914 | T/C | 1.04E-5 | 257 | 31.78 | 34.57 | 3.1 | KM Plot |
| SARC | rs17058346 | chr13:39195569 | A/G | 7.53E-6 | 258 | 10.67 | 35.57 | 30.93 | KM Plot |
| SARC | rs17075341 | chr4:185064237 | C/T | 3.38E-14 | 258 | 31.77 | 32.4 | 1.17 | KM Plot |
| SARC | rs17088876 | chr18:71823296 | A/G | 2.07E-5 | 256 | 31.98 | 31.97 | 6.43 | KM Plot |
| SARC | rs17088882 | chr18:71825961 | A/G | 2.1E-5 | 255 | 31.57 | 31.97 | 6.43 | KM Plot |